Correlation between VEGF and HIF-1alpha expression in human oral squamous cell carcinoma (Q40580533)

21 September 2017

Correlation between VEGF and HIF-1alpha expression in human oral squamous cell carcinoma (English)

1 reference

21 September 2017

Khaled M Mohamed

1

1 reference

21 September 2017

Anh Le

2

1 reference

21 September 2017

Hai Duong

3

1 reference

21 September 2017

Yidi Wu

4

1 reference

21 September 2017

Qunzhou Zhang

5

1 reference

21 September 2017

Diana V Messadi

6

1 reference

21 September 2017

1 April 2004

1 reference

Experimental and Molecular Pathology

21 September 2017

1 reference

21 September 2017

76

1 reference

21 September 2017

2

1 reference

21 September 2017

143-152

1 reference

Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.005

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.005

Re: Levels of hypoxia-inducible factor-1alpha during breast carcinogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.005

Vascular Permeability Factor, Fibrin, and the Pathogenesis of Tumor Stroma Formationa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.005

Vascular endothelial growth factor induces endothelial fenestrations in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.005

The biology of vascular endothelial growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.005

Tumor induction of VEGF promoter activity in stromal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.005

Vascular endothelial growth factor (VEGF) and its receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.005

Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.005

Tumor angiogenesis as a prognostic indicator in T2-T4 oral cavity squamous cell carcinoma: a clinical-pathologic correlation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.005

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.005

Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.005

In vitro replication and differentiation of normal human oral keratinocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.005

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.005

Post-transcriptional regulation of vascular endothelial growth factor by hypoxia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.005

Expression of vascular endothelial growth factor in human oral squamous cell carcinoma: its association with tumour progression and p53 gene status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.005

Vascular endothelial growth factor overproduced by tumour cells acts predominantly as a potent angiogenic factor contributing to malignant progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.005

Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.005

Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.005

Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.005

Induction of hypoxia-inducible factor-1alpha by transcriptional and translational mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.005

Angiogenesis during tumor progression in the oral cavity is related to reduced apoptosis and high tumor cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.005

HIF-1 alpha is required for solid tumor formation and embryonic vascularization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.005

Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.005

Targeting vascular endothelial growth factor (VEGF) for anti-tumor therapy, by anti-VEGF neutralizing monoclonal antibodies or by VEGF receptor tyrosine-kinase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.005

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.005

Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.005

Hypoxia-inducible factor 1: control of oxygen homeostasis in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.005

Hypoxia Response Elements in the Aldolase A, Enolase 1, and Lactate Dehydrogenase A Gene Promoters Contain Essential Binding Sites for Hypoxia-inducible Factor 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.005

Hypoxic induction of HIF-1alpha and VEGF expression in head and neck squamous cell carcinoma lines is mediated by stress activated protein kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.005

Hypoxia-inducible factor 1alpha protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.005

Angiogenesis in the uterus: potential regulation and relation to tumor angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.005

Purification and characterization of hypoxia-inducible factor 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.005

Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.005

10.1016/J.YEXMP.2003.10.005

7 January 2021

Identifiers

DOI

1 reference

21 September 2017

1 reference